Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium

Hum Gene Ther. 1994 Feb;5(2):209-19. doi: 10.1089/hum.1994.5.2-209.
No abstract available

MeSH terms

  • Adenoviruses, Human* / physiology
  • Administration, Intranasal
  • Clinical Protocols
  • Containment of Biohazards
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / therapy*
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Defective Viruses* / physiology
  • Epithelium
  • Evaluation Studies as Topic
  • Genetic Therapy* / adverse effects
  • Genetic Therapy* / methods
  • Genetic Vectors*
  • Humans
  • Membrane Proteins / genetics
  • Nasal Mucosa*
  • Risk
  • Safety
  • Virus Replication

Substances

  • CFTR protein, human
  • Membrane Proteins
  • Cystic Fibrosis Transmembrane Conductance Regulator